Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development

WARREN, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announces its Artificial Intelligence effort, Tevogen AI, has joined Microsoft (Nasdaq: MSFT) for Startups. This partnership marks a significant milestone for Tevogen, providing unparalleled access to Microsoft’s extensive

Denmark Launches Leading Sovereign AI Supercomputer to Solve Scientific Challenges With Social Impact

NVIDIA founder and CEO Jensen Huang joined the king of Denmark to launch the country’s largest sovereign AI supercomputer, aimed at breakthroughs in quantum computing, clean energy, biotechnology and other areas serving Danish society and the world. Denmark’s first AI supercomputer, named Gefion after a goddess in Danish mythology, is an NVIDIA DGX SuperPOD driven Read Article